Anterior chamber migration of dexamethasone intravitreal implant (Ozurdex®) through basal iridectomy (Ando) in a pseudophakic patient

Alexandr Stepanov, Marco Codenotti, Andrea Ramoni, Matteo Prati, Nada Jiraskova, Pavel Rozsival, Francesco Bandello

Research output: Contribution to journalArticle

Abstract

Purpose: Intravitreal implantation of dexamethasone implant (Ozurdex®) is being widely used for the treatment of macular edema (ME) after branch or central retinal vein occlusion, diabetic ME, and persistent ME associated with uveitis or Irvine-Gass syndrome. We describe a complication: migration of the dexamethasone implant into the anterior chamber through basal iridectomy (Ando) in a pseudophakic patient with development of corneal edema and secondary high intraocular pressure. Methods: This is a case report of migration of Ozurdex® through basal iridectomy in a pseudophakic patient with iris claw lens. Conclusions: Pseudophakic patients, with a history of vitrectomy, even those with a basal iridectomy (Ando), are at high risk for migration of the Ozurdex® into the anterior chamber and development of corneal edema.
Original languageEnglish
Pages (from-to)e52 - e54
JournalEuropean Journal of Ophthalmology
Volume26
Issue number3
DOIs
Publication statusPublished - Nov 25 2015

Keywords

  • Ando iridectomy
  • Dexamethasone implant
  • Migration
  • Ozurdex®

ASJC Scopus subject areas

  • Medicine(all)
  • Ophthalmology

Fingerprint Dive into the research topics of 'Anterior chamber migration of dexamethasone intravitreal implant (Ozurdex®) through basal iridectomy (Ando) in a pseudophakic patient'. Together they form a unique fingerprint.

  • Cite this